Why the Corporate Travel Management Ltd share price is going gangbusters

The Corporate Travel Management (ASX:CTD) share price has crushed the returns of Domino's Pizza Enterprises Ltd (ASX:DMP).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Corporate Travel Management (ASX: CTD) are up 1,093% over the past five years to mean it is the best-performing member of the S&P/ASX 200 (Index: ^AJXO) (ASX: XJO) index of leading companies over the period.

Corporate Travel has even crushed the performance of the much hyped pizza delivery business and fellow digital retailer of sorts in Domino's Pizza Enterprises Ltd (ASX: DMP).

Below is a comparative chart of the two companies' performance over the last five years.

 Chart: Share price performance of Corporate Travel v Domino's Pizza over past 5 years (Source: Google Finance).

Corporate Travel's rise is a textbook example of why investors should often avoid over-hyped and over-valued stocks such as Domino's Pizza to focus on fast growers that actually trade on reasonable valuations, relative to their growth rates and outlooks.

Corporate Travel for example is set to post a statutory earnings per share (EPS) compound annual growth rate (CAGR) of greater than 30%, yet has commonly traded on earnings multiples around 30 over the past years.

This means it has traded on a price-to-earnings growth (PEG) ratio around 1, which shows it represented good value according to common valuation metrics for growth stocks.

Investors who recognized this over the past five years will be sitting on blockbuster gains today, but when it comes to investing it's the next five years that counts.

Outlook

In a presentation to analysts today, Corporate Travel's management reconfirmed that it expects to post full year EBITDA (operating income) of greater than $97 million, which would be a minimum of 40.6% up on FY 2016.

Evidently the business will find it harder to maintain these sorts of EBITDA growth rates as it builds scale and cycles off a larger base, but there are many signs that point to a strong FY 2018.

The company has repeatedly noted that it "continues to win market share at an accelerating in 2HFY17" and that it expects "good momentum into FY18".

As the company also notes demand for corporate travel is always leveraged to global economic conditions particularly in the world's largest markets like the U.S. and Europe that are now exhibiting signs of growing economic strength.

Anyone who has ever worked at a company where staff regularly travel will know that in times of feeble economic growth, or poor business performance, corporate travel is one of the first costs to be cut back on.

However, when things are ticking along nicely demand for corporate travel services naturally increases as budgets and business horizons expand.

Just today the U.S. Federal Reserve lifted lending rates again in a sign that the world's largest economy should enjoy a strong period over the travel group's FY 2018.

Although Corporate Travel's earnings growth rates will find it hard to keep up with the previous years of explosive growth, I expect it could deliver another strong year of growth in FY 2018 to justify today's valuation of $23.64 per share.

In fact shorting Corporate Travel shares (or betting on them falling) over the last few years has proven a one-way ticket to Centrelink for traders and given the culture of sales-driven organic growth that aligns the financial interests of the staff and company together I expect this stock could head higher over time.

Motley Fool contributor Tom Richardson owns shares of Corporate Travel Management Limited. You can find Tom on Twitter @tommyr345 The Motley Fool Australia owns shares of Corporate Travel Management Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »